EUVIMEDEUVIMED entdecken
Crossref

Impacts of β‐thalassemia/hemoglobin E disease on pregnancy outcomes

Puntira Anuruksuwan, Sirinart Sirilert, Suchaya Luewan, Theera Tongsong iD

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Puntira Anuruksuwan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: beta-Thalassemia, Pregnancy Outcome, Premature Birth, Hemoglobin E. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare obstetric outcomes between women with β‐thalassemia/hemoglobin E (β‐thal/HbE) disease and those of low‐risk pregnancies, and also between the two subgroups, β‐thal 0 /HbE and β‐thal + /HbE disease.

Methods

A retrospective cohort study was undertaken on pregnant women with β‐thal/HbE disease and low‐risk pregnancies, which were randomly selected with a case‐to‐control ratio of 1:10.

Results

Pregnancies with β‐thal/HbE disease were identified in 0.19% of 59 152 pregnancies, including 104 women in the study group and 1040 women in the control group. The mean gestational age and mean birth weight were significantly lower in the study group. The prevalence of fetal growth restriction, preterm birth and low birth weight were significantly increased in the study group based on both univariate and multivariate analysis. The impacts were more striking in the β‐thal 0 /HbE subgroup than in the β‐thal + /HbE subgroup. The cesarean rate was significantly higher in the study group. No maternal death or serious complication was found in this cohort.

Conclusion

Based on this cohort, the largest ever published, β‐thal/HbE disease is significantly associated with increased incidence of fetal growth restriction, preterm birth and low birth weight. The impacts were more pronounced in the β‐thal 0 /HbE subgroup. Pregnancy may be relatively safer for women with β‐thal/HbE disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaPregnancy OutcomePremature BirthHemoglobin EInfant, Low Birth WeightFetal Growth RetardationHumansFemalePregnancyRetrospective StudiesAdultInfant, NewbornPregnancy Complications, HematologicCase-Control StudiesGestational AgeCesarean SectionBirth WeightYoung Adult

Stichwörter der Autor:innen

fetal growth restrictionhemoglobin Epregnancy outcomepreterm birththalassemia/Hb E diseaseβ‐thalassemia

Substanzen

Hemoglobin E

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Theera Tongsong

Förderung

  • Chiang Mai University

Zitieren

APA

Anuruksuwan, P., Sirilert, S., Luewan, S., & Tongsong, T. (2024). Impacts of β‐thalassemia/hemoglobin E disease on pregnancy outcomes. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15360

Vancouver

Anuruksuwan P, Sirilert S, Luewan S, Tongsong T. Impacts of β‐thalassemia/hemoglobin E disease on pregnancy outcomes. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15360

BibTeX
@article{Anuruksuwan2024,
  author = {Anuruksuwan, Puntira and Sirilert, Sirinart and Luewan, Suchaya and Tongsong, Theera},
  title = {Impacts of β‐thalassemia/hemoglobin E disease on pregnancy outcomes},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15360}
}
Kostenlos starten →